WilliamRobertLevisMD

Dermatology • New York, NY

Physician

Join to view full profile

Dr. Levis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Levis' full profile

Already have an account?

Office
462 1st Ave
New York, NY 10016
Phone+1 917-913-4187

Fax+1 212-263-8423

Education & Training

National Institutes of Health Clinical CenterResidency, Dermatology, 1966 - 1969
Oregon Health & Science University (OHSU Health)Residency, Dermatology, 1965 - 1966
University of Washington School of MedicineInternship, Transitional Year, 1964 - 1965
University of Wisconsin School of Medicine & Public HealthClass of 1964

Certifications & Licensure

NY State Medical License 1981 - 2025
MA State Medical License 1994 - 2021
NJ State Medical License 1992 - 1997
MD State Medical License 1972 - 1982
WI State Medical License 1970 - 1975
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

Elected Member The American Society for Clinical Investigation, 1979

Publications & Presentations

PubMed

21 citations
Mycobacterial carbohydrate antigens for serological testing of patients with leprosy.
William R. Levis, Harry C. Meeker, Georgia Schuller-Levis, Eugene A. Sersen, Patrick J. Brennan
The Journal of Infectious Diseases. 1987-11-01
1 citations
In Vitro Clonal Priming Data Suggests Mechanism for Lower Initial Vaccine Dose Yielding Increased Immunity in Astra-Zeneca Vaccine Trial.
Alan M. Dattner, Frank Martiniuk, William R Levis
Journal of Drugs in Dermatology. 2021-04-01
3 citations
Studies on the contact sensitization of man with simple chemicals: V. Clonal priming allows direct in vitro assessment of autologous HLA-associated factors required fo...
Alan M. Dattner, Dean L. Mann, William R. Levis
The Journal of Investigative Dermatology. 1979-09-01

Press Mentions

XBiotech Announces Addition of Renowned Dermatologist Dr. William Levis to Its Scientific Advisory BoardOctober 3rd, 2017
Leprosy Is Still with Us – Even in New Jersey – but "100 Percent Curable"July 13th, 2017
Leprosy Seen as Just Another Curable Disease at NYC ClinicMay 1st, 2017
Join now to see all